Global X電玩與電競ETF HERO 深 滬
等待開盤 06-26 09:30:00 美东时间
23.5519
-0.233
-0.98%
華盛通- 最 高23.78
- 今 開23.78
- 成交量 1.02万股
- 最 低 23.51
- 昨 收 23.785
- 總市值 5936.00万
- 52周最高 34.3471
- 市盈率 靜 --
- 換手率 0.40%
- 52周最低 23.51
- 委 比 0.05%
- 總股本 252.04万
- 歷史最高 36.0763
- 量 比 1.10
- 振 幅 1.14%
- 歷史最低 12.6042
- 每 手 1
- 風險率 2.85%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多HEROZ Publishes Excerpt of FY04/2026 Full-Year Financial Results
HEROZ, Inc. ( ($JP:4382) ) just unveiled an update. HEROZ, Inc. released an Eng...
06-15 14:58
BRIEF-Uber Weighs Delivery Hero Asset Sales To Smooth Full Takeover - Bloomberg News
BRIEF-Uber Weighs Delivery Hero Asset Sales To Smooth Full Takeover - Bloomberg News June 12 (Reuters) - UBER WEIGHS DELIVERY HERO ASSET SALES TO SMOOTH FULL TAKEOVER - BLOOMBERG NEWS UBER HAS BEEN SOUNDING OUT COMPANIES THAT COULD BUY DELIVERY HERO ASSETS IN OVERLAPPING REGIONS WITHIN LATIN AMERICA
06-12 22:18
BRIEF-Delivery Hero Confirms Approach By Uber Technologies’ With Respect To Potential Takeover Offer
BRIEF-Delivery Hero Confirms Approach By Uber Technologies’ With Respect To Potential Takeover Offer May 23 (Reuters) - Delivery Hero SE DHER.DE : EQS-ADHOC: DELIVERY HERO CONFIRMS APPROACH BY UBER TECHNOLOGIES’ WITH RESPECT TO POTENTIAL TAKEOVER OFFER DELIVERY HERO SE - CONFIRMS APPROACH BY UBER TE
05-23 21:59
BRIEF-Uber And Doordash Sound Out Investors For Delivery Hero Bid- FT
BRIEF-Uber And Doordash Sound Out Investors For Delivery Hero Bid- FT May 23 (Reuters) - UBER AND DOORDASH SOUND OUT INVESTORS FOR DELIVERY HERO BID- FT UBER AND DOORDASH HAVE BOTH ENGAGED IN DISCUSSIONS ABOUT ACQUIRING MULTIPLE INVESTORS’ STAKES IN DELIVERY HERO IN RECENT DAYS- FT INVESTORS HAVE IN
05-23 21:04
Vuzix Reports Q1 2026 Results: Full Earnings Call Transcript
On Thursday, Vuzix (NASDAQ:VUZI) discussed first-quarter financial results duri...
05-15 05:00
Aardvark Therapeutics Says FDA Places Full Clinical Hold On Its Investigational New Drug Application For ARD-101 Related To Prior Announced Voluntary Pause
Aardvark Therapeutics, Inc. (Aardvark or the Company) (NASDAQ:AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the
05-15 04:04
Matson Q1 2026 Earnings Call: Complete Transcript
Matson (NYSE:MATX) released first-quarter financial results and hosted an earni...
05-05 05:22
Church & Dwight CEO Warns Of Middle East-Driven Inflation, But Calls It 'Transitory'
Church & Dwight Co., Inc. Q1 beats estimates as organic sales jump 5% and margins expand, offsetting inflation and tariff pressures.
05-02 01:53
Longleaf Partners Global Fund exits BIO, DIS among Q1 moves
Longleaf Partners Global Fund said that it ended the first quarter of 2026 with a P/V in the mid-50s%. The fund, in its quarterly commentary, said that FedEx (FDX) and Glanbia (GLAPY) were top contrib...
04-21 00:16
